Purpose of the Bill

The purpose of this bill is to ensure continued access to affordable prescription drugs through the 340B Drug Pricing Program by preventing drug manufacturers from interfering with such access. This is aimed at supporting healthcare facilities that rely on these discounted medications to provide low-cost services.

Main Provisions

• The bill effectively extends the prohibition on drug manufacturers that might attempt to interfere with access to 340B drugs, a program that allows certain health care providers to purchase medications at reduced prices.
• By repealing the scheduled expiration of relevant statutes, the bill seeks to maintain uninterrupted enforcement of the rules that ensure compliance by drug manufacturers.

Significant Changes

• This bill repeals the expiration provision (previously set for July 1, 2027) within Minnesota Statutes 2024 section 62J.96 subdivision 3, which means the prohibition on manufacturers interfering with the 340B drug access will not expire as initially planned. This change makes the previous restrictions indefinite, providing long-term protection against interference.

Relevant Terms

• 340B Drug Pricing Program
• Drug manufacturers
• Access to affordable medication
• Interference prohibition
• Cost reductions
• Healthcare facilities